[Studies of the mechanisms of human B-cell activation. II. The role of resting B-cell abnormalities in the pathogenesis of systemic lupus erythematosus].
D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology*; D005260:Female; D006133:Growth Substances / Q000494:pharmacology; D006801:Humans; D015847:Interleukin-4; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008222:Lymphokines / Q000494:pharmacology; D008875:Middle Aged; D013211:Staphylococcus aureus / Q000276:immunology
D006133:Growth Substances; D008222:Lymphokines; D015847:Interleukin-4